KORU Medical Systems (NASDAQ:KRMD - Get Free Report) is projected to release its Q1 2025 earnings data after the market closes on Wednesday, May 7th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $8.86 million for the quarter.
KORU Medical Systems Stock Performance
Shares of KORU Medical Systems stock traded up $0.10 during trading on Friday, reaching $2.85. The company's stock had a trading volume of 164,269 shares, compared to its average volume of 140,653. The business's fifty day moving average price is $2.69 and its 200-day moving average price is $3.37. KORU Medical Systems has a one year low of $1.86 and a one year high of $5.05. The firm has a market cap of $131.50 million, a price-to-earnings ratio of -11.40 and a beta of 0.87. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.37 and a current ratio of 2.99.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the company. Craig Hallum increased their price objective on KORU Medical Systems from $5.00 to $6.00 and gave the company a "buy" rating in a research report on Friday, January 17th. Piper Sandler reissued a "neutral" rating and issued a $4.50 price target on shares of KORU Medical Systems in a report on Friday, February 14th. B. Riley raised KORU Medical Systems to a "strong-buy" rating in a research report on Thursday, March 13th. Finally, Lake Street Capital upped their price target on KORU Medical Systems from $4.00 to $5.00 and gave the company a "buy" rating in a report on Tuesday, January 14th. One research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, KORU Medical Systems presently has a consensus rating of "Buy" and an average target price of $4.70.
Get Our Latest Stock Analysis on KORU Medical Systems
KORU Medical Systems Company Profile
(
Get Free Report)
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
See Also
Before you consider KORU Medical Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KORU Medical Systems wasn't on the list.
While KORU Medical Systems currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
